A new CMA policy on prescription drug shortages in Canada calls for a review of the drug supply system to identify underlying causes of supply problems and a monitoring unit to track drug production disruptions in Canada and abroad
A new CMA policy on prescription drug shortages in Canada calls for a review of the drug supply system to identify underlying causes of supply problems and a monitoring unit to track drug production disruptions in Canada and abroad